Article
Comparison of two preventive treatments for patients with recurrent miscarriages carrying a C677T methylenetetrahydrofolate reductase mutation: 5-year experience.
The Journal of international medical research - 1 Dec 2017
Merviel Philippe, Cabry Rosalie, Lourdel Emmanuelle, Lanta Segolene, Amant Carole, Copin Henri, Benkhalifa Moncef
Abstract excerpt
Objective To investigate the effect of anticoagulant treatment on pregnancy outcomes in patients with previous recurrent miscarriages (RM) who carry a methylenetetrahydrofolate reductase ( MTHFR) gene mutation. Methods In this longitudinal retrospective study, patients with RM were treated during pregnancy with either: (i) 100 mg/day aspirin and 5 mg/day folic acid (group 1); or the same protocol plus 0.4 mg/day...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
